Ledger.Open graph →
SEC Form D · filed January 2, 2024

Omnipulse Biosciences, Inc

Offering
$12.5M
Sold
$7.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Cambridge, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

David Zhu · Boston, MADirectorFelicia Hsu · Cambridge, MADirectorJoseph Desimone · Cary, NCPromoterRobert Langer · PITTSBURGH, PADirector · PromoterRobert Farra · Cambridge, MAExec · DirectorDavid Zhu · Boston, MADirectorJoseph Desimone · Cary, NCPromoterAna Jacklenec · Cambridge, MADirector · PromoterAna Jacklenec · Cambridge, MADirector · PromoterFelicia Hsu · Cambridge, MADirectorRobert Farra · Cambridge, MAExec · DirectorRobert Langer · Bedford, MADirector · Promoter

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗